4
Changes in Ownership
Outlook Therapeutics, Inc. Filed Acc 0001209191-23-024880
Options or other derivatives
- Chief Commercial Officer acquired 192,143 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Evanson Jeff · Chief Commercial Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-04-17 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +192,143 | 192,143 | D |
Loading xslF345X04/doc4.xml…